Epidemiology of systemic lupus erythematosus GJ Pons-Estel, MF Ugarte-Gil, GS Alarcón Expert review of clinical immunology 13 (8), 799-814, 2017 | 280 | 2017 |
A rush to judgment? Rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for COVID-19 AHJ Kim, JA Sparks, JW Liew, MS Putman, F Berenbaum, ... Annals of internal medicine 172 (12), 819-821, 2020 | 256 | 2020 |
Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population. DP De Leon, E Acevedo-Vasquez, S Alvizuri, C Gutierrez, M Cucho, ... The Journal of rheumatology 35 (5), 776-781, 2008 | 235 | 2008 |
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global Rheumatology Alliance … JA Sparks, ZS Wallace, AM Seet, MA Gianfrancesco, Z Izadi, KL Hyrich, ... Annals of the rheumatic diseases 80 (9), 1137-1146, 2021 | 215 | 2021 |
2021 DORIS definition of remission in SLE: final recommendations from an international task force RF van Vollenhoven, G Bertsias, A Doria, D Isenberg, E Morand, MA Petri, ... Lupus Science & Medicine 8 (1), e000538, 2021 | 175 | 2021 |
First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano … BA Pons-Estel, E Bonfa, ER Soriano, MH Cardiel, A Izcovich, F Popoff, ... Annals of the rheumatic diseases 77 (11), 1549-1557, 2018 | 157 | 2018 |
Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey SE Sattui, JW Liew, K Kennedy, E Sirotich, M Putman, TT Moni, A Akpabio, ... RMD open 7 (3), e001814, 2021 | 151 | 2021 |
The number of flares patients experience impacts on damage accrual in systemic lupus erythematosus: data from a multiethnic Latin American cohort MF Ugarte-Gil, E Acevedo-Vásquez, GS Alarcón, CA Pastor-Asurza, ... Annals of the rheumatic diseases 74 (6), 1019-1023, 2015 | 138 | 2015 |
Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL) MF Ugarte-Gil, D Wojdyla, GJ Pons-Estel, LJ Catoggio, C Drenkard, ... Annals of the rheumatic diseases 76 (12), 2071-2074, 2017 | 133 | 2017 |
SARS–CoV‐2 infection and COVID‐19 outcomes in rheumatic diseases: a systematic literature review and meta‐analysis R Conway, AA Grimshaw, MF Konig, M Putman, A Duarte‐García, ... Arthritis & Rheumatology 74 (5), 766-775, 2022 | 132 | 2022 |
Consumo de alcohol y drogas y factores psicosociales asociados en adolescentes de Lima E Salazar, M Ugarte, L Vásquez, J Loaiza Anales de la Facultad de Medicina 65 (3), 179-187, 2004 | 115 | 2004 |
Vaccination against COVID-19: expectations and concerns of patients with autoimmune and rheumatic diseases R Felten, M Dubois, MF Ugarte-Gil, A Chaudier, L Kawka, H Bergier, ... The Lancet Rheumatology 3 (4), e243-e245, 2021 | 110 | 2021 |
Obesity is independently associated with impaired quality of life in patients with rheumatoid arthritis A García-Poma, MI Segami, CS Mora, MF Ugarte, HN Terrazas, EA Rhor, ... Clinical rheumatology 26, 1831-1835, 2007 | 104 | 2007 |
Prevalencia de enfermedades reumatológicas y discapacidad en una comunidad urbano-marginal: resultados del primer estudio COPCORD en el Perú R Gamboa, M Medina, E Acevedo, C Pastor, J Cucho, C Gutiérrez, ... Rev Peruana Reumatol 15 (1), 40-46, 2009 | 92 | 2009 |
Tolerance of COVID-19 vaccination in patients with systemic lupus erythematosus: the international VACOLUP study R Felten, L Kawka, M Dubois, MF Ugarte-Gil, Y Fuentes-Silva, M Piga, ... The Lancet Rheumatology 3 (9), e613-e615, 2021 | 87 | 2021 |
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance MF Ugarte-Gil, GS Alarcón, Z Izadi, A Duarte-García, ... Annals of the rheumatic diseases 81 (7), 970-978, 2022 | 74 | 2022 |
Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort VR Pimentel-Quiroz, MF Ugarte-Gil, GB Harvey, D Wojdyla, GJ Pons-Estel, ... Lupus 28 (9), 1101-1110, 2019 | 74 | 2019 |
Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19 SE Sattui, JW Liew, ER Graef, A Coler-Reilly, F Berenbaum, ... Expert Review of Clinical Immunology 16 (7), 659-666, 2020 | 67 | 2020 |
Factors affecting quality of life in patients with systemic lupus erythematosus: important considerations and potential interventions C Elera-Fitzcarrald, A Fuentes, LA González, PI Burgos, GS Alarcón, ... Expert Review of Clinical Immunology 14 (11), 915-931, 2018 | 67 | 2018 |
Features associated with hematologic abnormalities and their impact in patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort LA González-Naranjo, OM Betancur, GS Alarcón, MF Ugarte-Gil, ... Seminars in Arthritis and Rheumatism 45 (6), 675-683, 2016 | 61 | 2016 |